Curaleaf Valuation Multiples
Discover Curaleaf's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Trulieve Cannabis, Green Thumb Industries, Cronos Group, Glass House Brands and more.
Curaleaf Overview
About Curaleaf
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
Founded
2014
HQ
Employees
5.5K
Website
Financials (LTM)
EV
$3.2B
Valuation Multiples
Start free trial
Curaleaf Financials
Curaleaf reported last 12-month revenue of $1.3B and EBITDA of $273M.
In the same LTM period, Curaleaf generated $642M in gross profit, $273M in EBITDA, and had net loss of ($158M).
Revenue (LTM)
Curaleaf P&L
In the most recent fiscal year, Curaleaf reported revenue of $1.3B and EBITDA of $275M.
Curaleaf is unprofitable as of last fiscal year, with gross margin of 50%, EBITDA margin of 22%, and net margin of (18%).
Financial data powered by Morningstar, Inc.
Curaleaf Stock Performance
Curaleaf has current market cap of $2.4B, and enterprise value of $3.2B.
Market Cap Evolution
Curaleaf's stock price is $9.24.
Curaleaf share price decreased by 14.3% in the last 30 days, and increased by 576.1% in the last year.
Curaleaf has an EPS (earnings per share) of $-0.87.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.2B | $2.4B | -4.2% | -14.3% | 165.1% | 576.1% | $-0.87 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCuraleaf Valuation Multiples
Curaleaf trades at 2.4x EV/Revenue multiple, and 11.6x EV/EBITDA.
EV / Revenue (LTM)
Curaleaf Financial Valuation Multiples
As of July 17, 2026, Curaleaf has market cap of $2.4B and EV of $3.2B.
Curaleaf has a P/E ratio of (15.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Curaleaf Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Curaleaf Margins & Growth Rates
Curaleaf grew revenue by 6% but EBITDA decreased by 1% in the last fiscal year.
In the most recent fiscal year, Curaleaf reported gross margin of 50%, EBITDA margin of 22%, and net margin of (18%).
Curaleaf Margins
Curaleaf Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Curaleaf Operational KPIs
Curaleaf's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Curaleaf's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Curaleaf's Rule of X is 35% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Curaleaf Competitors
Curaleaf competitors include Trulieve Cannabis, Green Thumb Industries, Cronos Group, Glass House Brands, Tilray Brands, Vireo Growth, Verano Holdings and Canopy Growth.
Most Curaleaf public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.6x | 1.8x | 4.4x | 5.0x | |||
| 1.5x | 1.5x | 3.7x | 5.2x | |||
| 1.4x | 1.2x | 171.9x | 13.1x | |||
| 6.2x | 5.7x | 66.6x | 43.2x | |||
| 0.8x | 0.7x | 11.5x | 10.0x | |||
| 2.8x | 1.6x | 10.1x | 5.8x | |||
This data is available for Pro users. Sign up to see all Curaleaf competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Curaleaf
Curaleaf has acquired 13 companies to date.
Last acquisition by Curaleaf was on March 19th 2024. Curaleaf acquired Northern Green Canada for $16M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Curaleaf
| Description | Northern Green Canada is a Val-d'Or-based licensed producer of recreational and medicinal cannabis products in Quebec, Canada. It cultivates strains like Northern Lights and distributes oils, edibles, and dried flower through provincial retail networks. The company operates a 25,000-square-foot facility compliant with Health Canada regulations. | Can4Med is a Warsaw-based licensed pharmaceutical wholesaler authorized for trading medicinal products, narcotics in groups I-N, and dried prescription drugs across Poland. The company supplies hospitals, pharmacies, and healthcare providers with a range of pharmaceuticals while complying with strict regulatory standards for storage and distribution. | Deseret Wellness is a cannabis therapy provider with cultivation, manufacturing, and dispensary operations in regulated medical markets. The team manages facilities in multiple US states, producing oils, edibles, and topicals from strains grown indoors. Deseret emphasizes compliance with state health departments for patient access programs. | Four 20 Pharma is a Mönchengladbach-based producer and distributor of medical cannabis products under full EU-GMP and GDP certification. It manufactures flower, oils, and extracts from strains like Bedrocan and Pedanios, supplying pharmacies across Germany and 12 European countries. The company operates a 2,000 square meter facility with cultivation greenhouses yielding 1,000 kg annually. Four 20 Pharma partners with Dutch growers for standardized cultivars since 2018. | |
| HQ Country |  |  |  |  | |
| HQ City | Toronto | Wroclaw | Provo, UT | Paderborn | |
| Deal Date | 19 Mar 2024 | 6 Feb 2024 | 29 Mar 2023 | 9 Aug 2022 | |
| Valuation | $16M | undisclosed | $20M | $36M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Curaleaf acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Curaleaf
| When was Curaleaf founded? | Curaleaf was founded in 2014. |
| Where is Curaleaf headquartered? | Curaleaf is headquartered in United States. |
| How many employees does Curaleaf have? | As of today, Curaleaf has over 5K employees. |
| Who is the CEO of Curaleaf? | Curaleaf's CEO is Boris Jordan. |
| Is Curaleaf publicly listed? | Yes, Curaleaf is a public company listed on OTCM. |
| What is the stock symbol of Curaleaf? | Curaleaf trades under CURLF ticker. |
| When did Curaleaf go public? | Curaleaf went public in 2018. |
| Who are competitors of Curaleaf? | Curaleaf main competitors include Trulieve Cannabis, Green Thumb Industries, Cronos Group, Glass House Brands, Tilray Brands, Vireo Growth, Verano Holdings, Canopy Growth. |
| What is the current market cap of Curaleaf? | Curaleaf's current market cap is $2.4B. |
| What is the current revenue of Curaleaf? | Curaleaf's last 12 months revenue is $1.3B. |
| What is the current revenue growth of Curaleaf? | Curaleaf revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Curaleaf? | Current revenue multiple of Curaleaf is 2.4x. |
| What is the current EBITDA of Curaleaf? | Curaleaf's last 12 months EBITDA is $273M. |
| What is Curaleaf's EBITDA margin? | Curaleaf's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Curaleaf? | Current EBITDA multiple of Curaleaf is 11.6x. |
| What is the current FCF of Curaleaf? | Curaleaf's last 12 months FCF is $54M. |
| What is Curaleaf's FCF margin? | Curaleaf's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Curaleaf? | Current FCF multiple of Curaleaf is 58.9x. |
| How many companies Curaleaf has acquired to date? | As of July 2026, Curaleaf has acquired 13 companies. |
| What was the largest acquisition by Curaleaf? | $949M acquisition of Cura Partners on 1st May 2019 was the largest M&A Curaleaf has done to date. |
| What companies Curaleaf acquired? | Curaleaf acquired Cura Partners, Grassroots Cannabis, Tryke, EMMAC Life Sciences, Bloom Dispensary, Acres Cannabis, Los Sueños Farms, Four 20 Pharma, Deseret Wellness, Northern Green Canada, and 3 other companies. |
| In how many companies Curaleaf has invested to date? | Curaleaf hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Curaleaf
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="28" height="28" viewBox="0 0 28 28"><rect fill="%23e5e7eb" width="28" height="28" rx="6"/></svg>){kind=small}
Lists including Curaleaf
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.